Cart 2

Varlilumab reference antibody

Cat.#: 176842

Size:

Special Price 112.9 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Varlilumab reference antibody
  • Documents
  • Description
    Anti-TNFRSF7 / CD27 Antibody (Varlilumab)
  • Tested applications
    ELISA
  • Species reactivity
    Human TNFRSF7 / CD27
  • Isotype
    IgG1
  • Preparation
    Recombinant expression and purified from CHO cells.
  • Clonality
    Monoclonal
  • Formulation
    0.1 M Pro-Ac, 20 mM Arg, pH 5.0
  • Storage instructions
    -80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
  • Validations

    SDS-PAGE

    SDS-PAGE

    Anti-TNFRSF7 / CD27 Antibody (varlilumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

    SEC-HPLC

    SEC-HPLC

    The purity of Anti-TNFRSF7 / CD27 Antibody (varlilumab) is 100%, determined by SEC-HPLC.

    Bioactivity: ELISA

    Bioactivity: ELISA

    Immobilized human CD27 FC at 2 ug/mL can bind Anti-TNFRSF7 / CD27 Antibody (varlilumab), EC50=0.01912 ug/mL.

    Bioactivity: FACS

    Bioactivity: FACS

    Human CD27 HEK293 cells were stained with Anti-TNFRSF7 / CD27 Antibody (varlilumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50=0.095 ug/mL.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"